Drugs / NVP
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00669487 Background | Apr 2008 → Dec 2010 | HIV infectious disease | SEARCH Research Foundation | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NVP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00669487 ↗ |
| Route | Oral | “Truvada(FTC200mg+TDF300mg) every 24 hours + NVP 200 mg every 12 hours orally until week 72” NCT00669487 ↗ |